Clinical trials
Terminated Phase 1/2 Neoplasm Metastasis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
84 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2008 | 3 |
| 2009 | 6 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 6 |
| 2013 | 1 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 7 |
| 2018 | 7 |
| 2019 | 7 |
| 2020 | 5 |
| 2021 | 15 |
| 2022 | 7 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 84 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 8 |
| M.D. Anderson Cancer Center | 3 |
| NextCure, Inc. | 3 |
| Altor BioScience | 2 |
| Bristol-Myers Squibb | 2 |
| Deciphera Pharmaceuticals, LLC | 2 |
| Fred Hutchinson Cancer Center | 2 |
| Incyte Corporation | 2 |
| NantCell, Inc. | 2 |
| Takeda | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 84 |
| Carcinoma, Non-Small-Cell Lung | 16 |
| Melanoma | 16 |
| Neoplasms | 13 |
| Ovarian Neoplasms | 13 |
| Breast Neoplasms | 12 |
| Lung Neoplasms | 12 |
| Colorectal Neoplasms | 10 |
| Recurrence | 10 |
| Stomach Neoplasms | 9 |
Trials
Showing 1 to 25 of 84. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.